Show simple item record

dc.contributor.authorMammadov, R.en_US
dc.contributor.authorDuman, E.en_US
dc.contributor.authorGuler, M. O.en_US
dc.contributor.authorTekinay, A. B.en_US
dc.date.accessioned2018-04-12T13:54:15Z
dc.date.available2018-04-12T13:54:15Z
dc.date.issued2013en_US
dc.identifier.isbn9781626181144
dc.identifier.urihttp://hdl.handle.net/11693/38371
dc.description.abstractAlbeit the roles of growth factors (e.g. VEGF) and their receptors in angiogenesis have been emphasized extensively, the indispensable role of glycosaminoglycans, especially heparan sulfates, has been discerning recently. These sugar polymers act as coreceptors for many growth factors, such as three key angiogenic growth factors: VEGF, FGF-2 and PDGF. Binding of heparan sulfates to growth factors enhances growth factor receptor interaction, and effect of signaling. To exploit the activatory role of heparan sulfates in induction of angiogenesis, researchers designed materials either carrying heparin or functional groups mimicking heparin. Here, we review our recent efforts in producing heparin mimetic materials for angiogenesis. Briefly, we designed novel peptide nanofiber scaffolds that can bind to growth factors similar to heparin, while inducing in vitro and in vivo angiogenesis. This material can provide a useful platform for therapy of chronic wound healing, where angiogenesis is impaired.en_US
dc.language.isoEnglishen_US
dc.source.titleAngiogenesis: Insights from a Systematic Overviewen_US
dc.titleThe role of heparin mimetic peptide nanofibers in angiogenesis processen_US
dc.typeBook Chapteren_US
dc.departmentUNAM - Institute of Materials Science and Nanotechnology
dc.departmentNANOTAM - Nanotechnology Research Center
dc.citation.spage199en_US
dc.citation.epage210en_US
dc.publisherNova Science Publishers, Inc.en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record